FDA
approval
· 2017-06-28
FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (GLENMARK THERAPEUTICS INC., USA)
Summary
FDA approves Glenmark's generic olopatadine hydrochloride ophthalmic solution for allergic conjunctivitis in an Original Application.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE OPHTHALMIC)